Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
Large-scale molecular profiling and genotyping provide a unique opportunity to systematically compare the genetically predicted effects of therapeutic targets on the human metabolome. We firstly constructed genetic risk scores for 8 drug targets on the basis that they primarily modify low-density li...
Saved in:
| Main Authors: | Tom G Richardson, Genevieve M Leyden, Qin Wang, Joshua A Bell, Benjamin Elsworth, George Davey Smith, Michael V Holmes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-02-01
|
| Series: | PLoS Biology |
| Online Access: | https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001547&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolomic characterisation of the glioblastoma invasive margin reveals a region-specific signature
by: James Wood, et al.
Published: (2025-01-01) -
Estimation of causal effects of a time-varying exposure at multiple time points through multivariable mendelian randomization.
by: Eleanor Sanderson, et al.
Published: (2022-07-01) -
Age at puberty and risk of asthma: A Mendelian randomisation study.
by: Cosetta Minelli, et al.
Published: (2018-08-01) -
The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach.
by: Børge G Nordestgaard, et al.
Published: (2012-01-01) -
Metabolome-wide Mendelian randomisation reveals causal links between circulating metabolites and type 1 diabetesResearch in context
by: Basile Jumentier, et al.
Published: (2025-07-01)